| 1 | 2-deoxy-2 [F-18] fluoro-2-d-glucose | 2件: D-glucose D-glucose,
Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol) | 1件: Glucose
Glucose
💬 | - | - | 1件: 49 49 💬 |
| 2 | 5% glucose water solution | 2件: Dextrose, unspecified form Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol),
Water | 1件: Water
Water
💬 | - | - | 1件: 2 2 💬 |
| 3 | [18F]Fluoro-2-deoxy-2-D-glucose | 2件: D-glucose D-glucose,
Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol) | 1件: Glucose
Glucose
💬 | - | - | 2件: 86 86, 88 💬 |
| 4 | D-glucose | 2件: D-glucose D-glucose,
Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol) | 1件: Glucose
Glucose
💬 | - | - | 3件: 49 49, 86, 88 💬 |
| 5 | Glucose | 2件: D-glucose D-glucose,
Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol) | 1件: Glucose
Glucose
💬 | - | - | 12件: 2 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299 💬 |
| 6 | Glucose intake | 1件: Dextrose, unspecified form Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol) | - | - | - | 1件: 257 257 💬 |
| 7 | Glucose Tablet | 1件: Dextrose, unspecified form Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol) | - | - | - | 1件: 50 50 💬 |
| 8 | Modified Oral Glucose Tolerance Test (50g 4-hours) | 1件: Dextrose, unspecified form Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol) | - | - | - | 1件: 299 299 💬 |
| 9 | Oral Glucose Tolerance test (75g 2-hour) | 1件: Dextrose, unspecified form Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol) | - | - | - | 1件: 299 299 💬 |
| 10 | Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i) | 2件: Angiotensin II Angiotensin II,
Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol) | 2件: Angiotensin II
Angiotensin II
,
Angiotensin II
💬 | 2件: AGTR1 AGTR1,
AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬 |
| 11 | Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth | 2件: Dextrose, unspecified form Dextrose, unspecified form (Additive Solution Sodium Adenine Glucose Mannitol),
Sildenafil | 1件: Sildenafil
Sildenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |